Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China
· Delayed Price · Currency is CNY 8.93
-0.11 (-1.22%)
At close: Mar 9, 2026
SHA:600867 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 2,708 | 1,976 | 2,930 | 2,742 | 3,219 | 2,855 | Upgrade
|
| Other Revenue | 33.15 | 33.15 | 145.81 | 36.47 | 49.22 | 37.13 | Upgrade
|
| Revenue | 2,741 | 2,010 | 3,075 | 2,778 | 3,268 | 2,892 | Upgrade
|
| Revenue Growth (YoY) | 12.74% | -34.66% | 10.69% | -14.98% | 12.99% | 4.14% | Upgrade
|
| Cost of Revenue | 790.58 | 547.46 | 621.05 | 628.13 | 586.99 | 582.86 | Upgrade
|
| Gross Profit | 1,951 | 1,462 | 2,454 | 2,150 | 2,681 | 2,309 | Upgrade
|
| Selling, General & Admin | 1,354 | 1,252 | 1,047 | 1,114 | 1,255 | 1,091 | Upgrade
|
| Research & Development | 140.65 | 99.3 | 104.96 | 146.71 | 166.86 | 106.93 | Upgrade
|
| Other Operating Expenses | 25.33 | 13.13 | 11.65 | 14.57 | 11.27 | -34.35 | Upgrade
|
| Operating Expenses | 1,513 | 1,349 | 1,184 | 1,268 | 1,435 | 1,165 | Upgrade
|
| Operating Income | 437.6 | 113.02 | 1,270 | 882.29 | 1,246 | 1,145 | Upgrade
|
| Interest Expense | -21.81 | -14.38 | -5.17 | -0.28 | - | -10.17 | Upgrade
|
| Interest & Investment Income | 1,211 | 130.82 | 103.61 | 942.66 | 304.32 | 43.64 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.7 | 0.7 | 0.47 | 0 | 0.24 | -0.45 | Upgrade
|
| Other Non Operating Income (Expenses) | 251.31 | -1.14 | -1.65 | -0.88 | 0.33 | -7.38 | Upgrade
|
| EBT Excluding Unusual Items | 1,878 | 229.02 | 1,368 | 1,824 | 1,550 | 1,170 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.4 | 0.52 | 0.96 | -0.37 | 0.37 | Upgrade
|
| Gain (Loss) on Sale of Assets | -255.35 | -239.83 | -3.13 | -0.11 | -13.48 | -62.44 | Upgrade
|
| Asset Writedown | -106.24 | -80.68 | -7 | -1.74 | -11.53 | - | Upgrade
|
| Legal Settlements | -60.82 | -60.82 | - | - | - | - | Upgrade
|
| Other Unusual Items | -44.03 | 8.16 | 7.91 | 6.62 | 9.35 | - | Upgrade
|
| Pretax Income | 1,412 | -143.75 | 1,366 | 1,830 | 1,534 | 1,108 | Upgrade
|
| Income Tax Expense | 201.78 | -99.63 | 197.97 | 247.69 | 225.86 | 177.81 | Upgrade
|
| Earnings From Continuing Operations | 1,210 | -44.12 | 1,168 | 1,582 | 1,309 | 930.32 | Upgrade
|
| Minority Interest in Earnings | 15.69 | 1.4 | -0.09 | 0.06 | -0.34 | -0.41 | Upgrade
|
| Net Income | 1,226 | -42.72 | 1,168 | 1,582 | 1,308 | 929.92 | Upgrade
|
| Net Income to Common | 1,226 | -42.72 | 1,168 | 1,582 | 1,308 | 929.92 | Upgrade
|
| Net Income Growth | 259.17% | - | -26.17% | 20.92% | 40.69% | 14.63% | Upgrade
|
| Shares Outstanding (Basic) | 1,955 | 2,136 | 1,979 | 2,002 | 2,044 | 2,022 | Upgrade
|
| Shares Outstanding (Diluted) | 1,955 | 2,136 | 1,979 | 2,002 | 2,044 | 2,022 | Upgrade
|
| Shares Change (YoY) | -8.58% | 7.92% | -1.15% | -2.04% | 1.12% | -0.32% | Upgrade
|
| EPS (Basic) | 0.63 | -0.02 | 0.59 | 0.79 | 0.64 | 0.46 | Upgrade
|
| EPS (Diluted) | 0.63 | -0.02 | 0.59 | 0.79 | 0.64 | 0.46 | Upgrade
|
| EPS Growth | 292.86% | - | -25.32% | 23.44% | 39.13% | 15.00% | Upgrade
|
| Free Cash Flow | 213.89 | -108.99 | 513.4 | 370.21 | 579.62 | 712.69 | Upgrade
|
| Free Cash Flow Per Share | 0.11 | -0.05 | 0.26 | 0.18 | 0.28 | 0.35 | Upgrade
|
| Dividend Per Share | 0.250 | 0.250 | 0.250 | 0.500 | 0.300 | 0.210 | Upgrade
|
| Dividend Growth | - | - | -50.00% | 66.67% | 42.86% | 5.00% | Upgrade
|
| Gross Margin | 71.16% | 72.76% | 79.81% | 77.39% | 82.04% | 79.85% | Upgrade
|
| Operating Margin | 15.96% | 5.62% | 41.31% | 31.75% | 38.12% | 39.57% | Upgrade
|
| Profit Margin | 44.72% | -2.13% | 37.97% | 56.93% | 40.03% | 32.15% | Upgrade
|
| Free Cash Flow Margin | 7.80% | -5.42% | 16.69% | 13.32% | 17.74% | 24.64% | Upgrade
|
| EBITDA | 625.44 | 300.02 | 1,456 | 1,033 | 1,389 | 1,299 | Upgrade
|
| EBITDA Margin | 22.81% | 14.93% | 47.35% | 37.20% | 42.51% | 44.92% | Upgrade
|
| D&A For EBITDA | 187.84 | 187 | 185.87 | 151.17 | 143.65 | 154.54 | Upgrade
|
| EBIT | 437.6 | 113.02 | 1,270 | 882.29 | 1,246 | 1,145 | Upgrade
|
| EBIT Margin | 15.96% | 5.62% | 41.31% | 31.75% | 38.12% | 39.57% | Upgrade
|
| Effective Tax Rate | 14.29% | - | 14.49% | 13.54% | 14.72% | 16.05% | Upgrade
|
| Revenue as Reported | 2,741 | 2,010 | 3,075 | 2,778 | 3,268 | - | Upgrade
|
| Advertising Expenses | - | 93.24 | 63.59 | 46.79 | 143.61 | 120.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.